EHMT2 and breast carcinoma: Therefore, we assessed the relationship between the expression of EHMT2 and Beclin-1 and the survival rate of breast cancer patients from two large datasets, the Netherlands Cancer Institute (NKI) and University of North Carolina (UNC) cohorts.